ET was the first to report in July last year that global and domestic PE funds were in initial discussions to purchase a minority stake in the drugmaker, whose portfolio includes Covid-19 drugs remdesivir, favipiravir, molnupiravir and baricitinib in India. It is also the exclusive manufacturing partner of Cipla for remdesivir.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/356Zono
via IFTTT
0 comments:
Post a Comment